Myovant Sciences' uterine fibroids combo therapy meets main goal in study
May 14, 2019 at 07:38 AM EDT
Myovant Sciences Ltd on Tuesday said its combination therapy met the main goal of a late-stage study testing the treatment in women with uterine fibroids.